Page last updated: 2024-08-26

sivelestat and Pancreatic Neoplasms

sivelestat has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, XY; Kamohara, H; Mita, S; Ogawa, M; Sakamoto, K	1

Other Studies

1 other study(ies) available for sivelestat and Pancreatic Neoplasms

Article	Year
Neutrophil elastase inhibitor (ONO-5046.Na) suppresses the proliferation, motility and chemotaxis of a pancreatic carcinoma cell line, Capan-1. Research communications in molecular pathology and pharmacology, 1997, Volume: 98, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Movement; Chemotaxis; Glycine; Humans; Leukocyte Elastase; Pancreatic Neoplasms; Serine Proteinase Inhibitors; Sulfonamides; Tumor Cells, Cultured	1997

Article

Year

Neutrophil elastase inhibitor (ONO-5046.Na) suppresses the proliferation, motility and chemotaxis of a pancreatic carcinoma cell line, Capan-1.

Research communications in molecular pathology and pharmacology, 1997, Volume: 98, Issue:1

Topics: Adenocarcinoma; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Movement; Chemotaxis; Glycine; Humans; Leukocyte Elastase; Pancreatic Neoplasms; Serine Proteinase Inhibitors; Sulfonamides; Tumor Cells, Cultured

1997